- €52.12m
- €59.58m
- €88.17m
Brief: Vita 34 9-month Net Result Turns To Profit Of 1.05 Million Euros
Brief: Vita 34 H1 Net Profit At EUR 0.5 Million
Brief: Vita 34 Refocuses R&D Activities, Implements Cost Reduction Program In Scandinavia
Brief: Vita 34 Says Implements First Cost Reduction Measures
Brief: Vita 34 Q1 EBITDA Up By 50.9% At EUR 1.1 Mln
Brief: PBKM Updates On Its Stake In Stem Cell Bank In Germany
Brief: Vita 34 Q4 EBITDA At EUR 1.1 Mln
Brief: Vita 34 Q3 EBITDA up by 50 pct to EUR 1.1 mln
Brief: Vita 34 and Berlin Charité start joint research project
Brief: Vita 34 H1 net result swings to loss of EUR 1.0 mln
Brief: Vita 34 adjusts revenues and earnings targets for 2017
Brief: VITA 34 resolves on cash capital increase
Brief: Vita 34 elects new supervisory board members
Brief: Vita 34: elections to Supervisory Board
Brief: Vita 34 to cooperate with Romanian Besmax Life Solutions SRL
Brief: Vita 34 ag wins MK Beleggingsmaatschappij Venlo B.V. as new strategic investor
Brief: Vita 34 decides on a capital increase of around 10 pct
Brief: Vita 34 updates on planned capital increase and changes in management
Brief: Vita 34 AG CFO Falk Neukirch has resigned